戻る Agenda
Session 2 Track 2: Extrahepatic Delivery 1: Engineering LNPs and Ligand Conjugates for Oligonucleotide Delivery to the Kidney and Lung Tumors
Session Chair(s)
Elena Braithwaite, PHD
Toxicologist
FDA, United States
Jeffrey Foy, PHD
Executive Director, Toxicology
Nimbus Therapeutics, United States
Session 2 Track 2: Extrahepatic Delivery 1: Engineering LNPs and Ligand Conjugates for Oligonucleotide Delivery to the Kidney and Lung Tumors